Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.
Atia Vision has raised $28.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
Atia Vision's investors include Cormorant Asset Management, Shangbay Capital, Delos Capital, Rising Tide, The Capital Partnership.
Atia Vision is headquartered in Campbell, United States.
Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.
Atia Vision is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atia Vision — Funding & Investors." VCBacked, August 22, 2022, https://www.vcbacked.co/company/atia-vision. Accessed September 30, 2026.
VCBacked. (2022). Atia Vision — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/atia-vision
{{cite web |title=Atia Vision — Funding & Investors |url=https://www.vcbacked.co/company/atia-vision |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated